Characteristics

Number (n/N)

Percentage (%)

Current age (years)

[50 - 59]

118

59.30

[60 - 69]

59

29.65

≥70

22

11.06

Age at ART inclusion (years)

<50

153

76.88

>50

46

13.12

Sex, n (%)

Women

126

63.32

Men

73

36.68

HIV profile

1

178

89.45

2

18

9.05

1 + 2

3

1.51

Line of treatment at the time of study

First

190

95.48

Second

8

4.02

Third

1

0.50

WHO stage at inclusion

I

52

26.13

II

53

26.63

III

74

37.19

IV

20

10.05

Nadir TCD4+ lymphocyte counts (elements/mm³)

<200

111

55.78

≥200

88

44.22

Duration under ART(months)

<120

35

17.59

120 - 240

142

71.36

>240

22

11.06

Current therapeutic regimen

Without TDF

6

3.02

With TDF

193

96.08

Duration of TDF exposure

<10years

114

57.29

≥10 years

85

42.71

Current WHO stage

0.50

I

194

97.49

II

3

1.51

III

1

0.50

IV

1

0.50

Current viral load (copies/ml)

<40

196

98.49

>40

3

1.51